AAL

Penny Stock Gapping Higher on FDA News

TTOO stock is pacing for its best session ever

Managing Editor
Feb 28, 2019 at 10:42 AM
facebook X logo linkedin


Shares of T2 Biosystems Inc (NASDAQ:TTOO) are surging this morning, after the Food & Drug Administration (FDA) granted a "Breakthrough Device" designation for the company's gene diagnostic panel. At last check, TTOO is 29% higher at $4.86, pacing for its best session ever.

Analysts have been swift to voice their opinions on the FDA decision, with Canaccord Genuity calling it "unexpected good news," and reiterating a "buy" rating and $10 price target. Cantor Fitzgerald thinks the "Breakthrough Designation for T2Resistance further proves the unmet need of rapid-diagnostic testing for sepsis and antimicrobial resistance," maintaining an "overweight" rating and $11 price target on the stock -- more than double TTOO's current price. All four covering analysts sport "strong buy" ratings on the stock.

TTOO gapped higher on the charts today, and is set to close back above the 80-day moving average, which has been a ceiling of resistance for the shares since September. Furthermore, the stock has skyrocketed to a year-to-date gain of 70%.

Several short-term options traders are likely cheering the rally. T2 Biosystems' Schaeffer's put/call open interest ratio (SOIR) of 0.22 ranks in the 22nd percentile of its annual range. This suggests that short-term options traders are heavily favoring calls over puts, more so than usual.

On the other hand, a short squeeze could be underway. Short interest accounts for more than 9% of TTOO's total available float, and would take more than three weeks to buy back, at the equity's average pace of trading.

 

Two High-Octane Trade Ideas. One Simple Goal: Intraday Profits.

Dynamite Day Trading Signals delivers two same-day options trades every week — powered by proprietary intraday analysis and 43+ years of trading expertise.

But this isn’t just another stream of alerts.

It’s a structured plan with clear entry and exit points – designed for traders who want to act fast, trade smart, and wrap up gains before the closing bell.

No guesswork. No overnight exposure – Just two well-researched setups per week — whether you prefer buying premium or selling it.

And the results speak for themselves: subscribers have locked in +245.8% total profit over the last six months (since inception!).

👉 Start your one-month trial now for just $10, and be ready for the next trade alert.